Type 2 diabetes

Non-insulin dependent diabetes mellitus

Also known as: 인슐린 비의존성 당뇨병 Type 2 diabetes mellitus, 성인형 당뇨병, 제2형 당뇨병

Doctors who treat Type 2 diabetes

See all
Samsung Seoul Hospital Kim Jae-hyeon

Kim Jae-hyeon

Samsung Seoul Hospital · Endocrinology and Metabolism

당뇨병, 1형당뇨병, 부신질환

5.0
Kangbuk Samsung Hospital Moon Seon-jun

Moon Seon-jun

Kangbuk Samsung Hospital · Endocrinology and Metabolism

당뇨병(1형,2형, 췌장수술, 임신성당뇨병), 인공췌장클리닉(연속혈당측정, 인슐린펌프, 스마트펜) [제외: 갑상선(기능, 결절, 암 모두 제외), 부신질환, 뇌하수체질환, 골다공증, 부갑상선 질환]

5.0
Ajou University Hospital Kim Hye-jin

Kim Hye-jin

Ajou University Hospital · Endocrinology and Metabolism

당뇨병(1형·2형·임신성), 당뇨전단계, 대사증후군, 이상지질혈증, 비만, 갑상선 항진증, 갑상선 저하증, 갑상선 결절

5.0
Ajou University Hospital Jeon Ja-yeong

Jeon Ja-yeong

Ajou University Hospital · Endocrinology and Metabolism

당뇨병(1형·2형·임신성), 당뇨전단계, 대사증후군, 이상지질혈증, 비만, 갑상선 항진증, 갑상선 저하증, 갑상선 결절, 부갑상선 질환, 골다공증, 칼슘대사이상, 내분비질환, 부신종양, 부신기능이상, 뇌하수체질환

5.0
Seoul St. Mary's Hospital, Catholic University of Korea Lee Seung-hwan

Lee Seung-hwan

Seoul St. Mary's Hospital, Catholic University of Korea · Endocrinology and Metabolism

당뇨병,고지혈증,비만,뇌하수체/부신질환

5.0
Chosun University Hospital Kim Jin-hwa

Kim Jin-hwa

Chosun University Hospital · Endocrinology and Metabolism

당뇨병, 갑상선암, 갑상선질환

5.0
Chosun University Hospital Ryu Yeong-sang

Ryu Yeong-sang

Chosun University Hospital · Endocrinology and Metabolism

1형 당뇨, 갑상선암, 비만, 부신질환, 희귀내분비질환

5.0
Chungnam National University Hospital Lee Hyeon-seung

Lee Hyeon-seung

Chungnam National University Hospital · Endocrinology and Metabolism

내분비대사질환, 갑상선 및 갑상선 초음파, 골다공증, 당뇨병 및 대사증후군

5.0
Nowon Eulji University Hospital Jung Gyeong-yeon

Jung Gyeong-yeon

Nowon Eulji University Hospital · Endocrinology and Metabolism

갑상선, 당뇨, 골다공증, 뇌하수체, 부신

5.0
Seoul National University Bundang Hospital Lim Su

Lim Su

Seoul National University Bundang Hospital · Endocrinology and Metabolism

당뇨병, 고지혈증, 비만, 대사증후군

4.0

Disease Description (Causes and Symptoms)

  • Definition: Non-insulin-dependent diabetes mellitus = type 2 diabetes mellitus, a disease in which blood glucose levels chronically rise due to insufficient insulin secretion and/or insulin resistance in peripheral tissues.
  • Main pathophysiology: Genetic predisposition combined with environmental factors such as obesity, insufficient physical activity, and stress causes insulin resistance. Initially, compensatory insulin secretion increases, but later insulin secretion decreases due to impaired beta-cell function → persistent hyperglycemia.
  • Main symptoms: Polyuria, polydipsia (excessive thirst), polyphagia, weight loss (as the disease progresses), fatigue, blurred vision, numbness·abnormal sensation in the hands and feet, vulvar itching (women). Many cases are asymptomatic in the early stages.
  • Diagnostic criteria (main indicators):
    • Fasting blood glucose ≥ 126 mg/dL, or
    • 2-hour postprandial blood glucose (after a 75-g oral glucose tolerance test) ≥ 200 mg/dL, or
    • Random blood glucose (with accompanying symptoms) ≥ 200 mg/dL.
    • Supplementary indicator: Glycated hemoglobin (HbA1c) ≥ 6.5% is used to support diagnosis (repeat testing is recommended).

Treatment Methods

  • Lifestyle management (basic): Weight loss (in cases of obesity), regular aerobic and strength exercise, dietary therapy (total calorie control, carbohydrate distribution), smoking cessation, and limiting alcohol consumption.
  • Pharmacological treatment (general principles):
    • First-line medication: Metformin (start after checking kidney function).
    • Second-line/additional medications (selected according to patient characteristics and cardiovascular and kidney status): SGLT2 inhibitors (cardiovascular and kidney protective effects), GLP-1 receptor agonists (weight loss and cardiovascular benefits), DPP-4 inhibitors, sulfonylureas (blood glucose-lowering effects), thiazolidinediones, insulin (when necessary), etc.
    • Patients with a history of cardiovascular disease or impaired kidney function should consult a specialist when selecting medications (e.g., consider SGLT2 or GLP-1 agents).
  • Monitoring and targets: In general, an HbA1c target of <7% is usually recommended, but it should be individualized according to the patient’s age, comorbidities, risk of hypoglycemia, and other factors. Blood pressure and lipids (LDL-C) should also be managed together (e.g., a BP target of <130/80, tailored to the patient).
  • Treatment of acute complications: Ketoacidosis, hyperosmolar coma, and similar conditions require emergency treatment (hospitalization, intravenous fluids, and insulin treatment).
  • Vaccination: Consider vaccination against influenza, pneumococcus, and hepatitis B (for recommended 대상).
  • Precautions (self-management): Recognize symptoms of hypoglycemia (hyperventilation·tremor·sweating·confusion, etc.) and learn how to immediately consume fast-acting carbohydrates; monitor kidney and liver function and medication side effects; undergo regular eye, nerve, and kidney examinations and foot checks.

Checklist Before an Outpatient Visit (Including Example Questions)

Items/materials to prepare or submit:

  • List of currently used medications (including blood glucose-lowering drugs and blood pressure and lipid medications), and supplements (such as vitamins)
  • Recent blood glucose levels (self-monitoring records), glycated hemoglobin (HbA1c) test results (if available), and recent blood test results (creatinine·electrolytes·lipids)
  • Urinalysis results (urine albumin), if possible
  • Records of changes in weight·blood pressure·lifestyle (diet·exercise)
  • Records of symptom changes (polyuria·polydipsia·vision changes·delayed wound healing, etc.) and hypoglycemic episodes

Information to tell the doctor in advance before the consultation (examples):

  • Whether you have recently experienced symptoms of hypoglycemia or hyperglycemia
  • Whether you have other diseases (heart·kidney·liver), allergies, or are pregnant

General Example Questions to Ask the Doctor

  • "What are the side effects and precautions for this medication?"
  • "What should my target HbA1c be? What are the criteria for changing treatment?"
  • "Are there any additional tests I should undergo to prevent cardiovascular disease?"
  • "How should I respond immediately if hypoglycemia occurs?"

Examples of Condition-Specific Questions

  • "Based on my recent HbA1c (or fasting blood glucose·self-monitoring records), should my medication be added to or changed?"
  • "Considering my kidney function (creatinine/urine albumin), which blood glucose-lowering medication would be safe and effective?"

Additional information:

  • Regular ophthalmologic examinations (for retinopathy), kidney tests (urine albumin·glomerular filtration rate), and nerve and foot examinations (ulcer risk assessment) are recommended.

Patient stories: Type 2 diabetes

Talk with other Type 2 diabetes patientsAsk people who have been through itWrite

Hospitals that treat Type 2 diabetes

University hospitals where the doctors above see patients. Open a hospital to see its doctors by specialty and how to book.

Find top doctors for 'Type 2 diabetes'

Reviewed by · GoodDoctorNet medical specialists

This information is for general understanding only and does not replace diagnosis, prescription or treatment for an individual patient. If you have symptoms, please see a doctor.

Our medical content policy (in Korean) →